Bortezomib Enhances the Antitumor Effects of Interferon-β Gene Transfer on Melanoma Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 5, 2017-04 ,pp. : 754-761

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Therapy of Breast Cancer with a Radioiodinated Humanized Anti-EGP-1 Monoclonal Antibody: Advantage of a Residualizing Iodine Radiolabel

By Govindan Serengulam V.   Stein Rhona   Qu Zhengxing   Chen Susan   Andrews Philip   Ma Hong   Hansen Hans J.   Griffiths Gary L.   Horak Ivan D.   Goldenberg David M.  

Breast Cancer Research and Treatment, Vol. 84, Iss. 2, 2004-03 ,pp. : 173-182

Springer Publishing Company

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitor PTK/ZK Enhances the Antitumor Effects of Interferon-α/5-Fluorouracil Therapy for Hepatocellular Carcinoma Cells

By Murakami Masahiro  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 589-596

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells

By                    

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2947-2953

Spandidos Publications

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite